Key result
Moderate-to-severe AKI linked to higher mortality through 1 year in acute heart failure.
Why the study?
Does moderate-to-severe AKI worsen mortality compared to non-AKI or mild AKI in adult ICU patients with acute heart failure?
Cohort (n=5,136)
Does moderate-to-severe AKI worsen mortality compared to non-AKI or mild AKI in adult ICU patients with acute heart failure?
Answers are grounded in this paper and cite their sources.
In ICU patients with acute heart failure, moderate-to-severe AKI significantly worsens mortality up to 1 year, whereas mild or transient AKI (often from intensive decongestion) does not significantly impact long-term outcomes compared to no AKI.
Acute kidney injury (AKI) is a frequent complication in acute heart failure (AHF) patients, yet few studies have examined the prognostic implications of different dynamic KDIGO AKI stages in this population. This retrospective cohort study aimed to rigorously investigate the impact of dynamic KDIGO AKI staging on outcomes in ICU patients with AHF using robust statistical methods like propensity score matching and doubly robust analysis. Utilizing the MIMIC-IV database of 5136 adult AHF patients from 2008 to 2022, doubly robust analysis revealed no significant differences in 28-day, 180-day, and 1-year mortality between non-AKI and mild AKI groups. However, moderate-to-severe AKI had significantly higher mortality at all timepoints compared to normal or mild AKI. Patients exhibiting mild AKI, termed "subclinical AKI" as their prognosis often parallels non-AKI, face a markedly worsened outlook if their condition progresses to moderate-to-severe AKI during hospitalization. However, it is worth noting that further sensitivity analysis showed that in patients with AHF as the first diagnosis, transient AKI caused by intensive decongestion therapy and other interventions did not have a significant impact on long-term outcomes.
No takes yet. Share an insight, caveat, or question.
Jin et al. (2025) conducted a cohort in Acute heart failure (n=5,136). Moderate-to-severe acute kidney injury vs. Normal or mild AKI was evaluated on 28-day, 180-day, and 1-year mortality. Moderate-to-severe acute kidney injury was associated with significantly higher mortality at 28 days, 180 days, and 1 year compared to normal or mild AKI in patients with acute heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: